AI assistant
Natera, Inc. — Director's Dealing 2021
Jan 15, 2021
30253_dirs_2021-01-15_b8f9b44c-cdda-4dc3-b4ca-c800bb5fec64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-01-13
Reporting Person: Chapman Steven Leonard (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-13 | Common Stock | M | 1118 | $10.41 | Acquired | 38282 | Direct |
| 2021-01-13 | Common Stock | M | 1042 | $10.73 | Acquired | 39324 | Direct |
| 2021-01-13 | Common Stock | M | 1526 | $9.29 | Acquired | 40850 | Direct |
| 2021-01-13 | Common Stock | M | 1042 | $13.01 | Acquired | 41892 | Direct |
| 2021-01-13 | Common Stock | M | 1042 | $20.27 | Acquired | 42394 | Direct |
| 2021-01-13 | Common Stock | M | 2385 | $25.46 | Acquired | 45319 | Direct |
| 2021-01-13 | Common Stock | S | 8155 | $115 | Disposed | 37164 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-13 | Stock Option (right to buy) | $10.41 | M | 1118 | Disposed | 2027-06-08 | Common Stock (1118) | Direct |
| 2021-01-13 | Stock Option (right to buy) | $10.73 | M | 1042 | Disposed | 2027-07-13 | Common Stock (1042) | Direct |
| 2021-01-13 | Stock Option (right to buy) | $9.29 | M | 1526 | Disposed | 2028-03-08 | Common Stock (1526) | Direct |
| 2021-01-13 | Stock Option (right to buy) | $13.01 | M | 1042 | Disposed | 2029-01-10 | Common Stock (1042) | Direct |
| 2021-01-13 | Stock Option (right to buy) | $20.27 | M | 1042 | Disposed | 2029-04-11 | Common Stock (1042) | Direct |
| 2021-01-13 | Stock Option (right to buy) | $25.46 | M | 2385 | Disposed | 2030-03-26 | Common Stock (2385) | Direct |
Footnotes
F1: The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
F2: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
F3: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
F4: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
F5: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F6: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F7: The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.